| APOL1 | Apolipoprotein L1 |
| Asah1 | Lysosomal acid ceramidase |
| CMIP | lC-maf inducing protein |
| DN | Diabetes-associated nephropathy |
| EGF | Epidermal growth factor |
| eGFR | Estimated glomerular filtration rate |
| ESI | Electrospray ionization |
| FSGS | Focal and segmental glomerulosclerosis |
| Flt1 | Vascular endothelial growth factor receptor 1 |
| GalNAc | N-acetylgalactosamine |
| GlcCer | Glucosylceramide |
| GA | Asialo gangliosides |
| GD | Di-sialo gangliosides |
| GM | Mono-syalo gangliosides |
| GP | Penta-sialo gangliosides |
| GQ | Quadri-sialo gangliosides |
| GSL-1 | Glycosphingolipid-1 |
| GT | Tri-sialo gangliosides |
| HDL | High density lipoproteins |
| HPTLC | High performance thin layer chromatography |
| INS | Idiopathic nephrotic syndrome |
| LacCer | Lactosylceramide |
| MALDI | Matrix assisted laser desorption ionization |
| MCNS | Minimal change nephotic syndrome |
| NEU | Neuraminidase |
| PAN | Puromycin aminonucleoside nephropathy |
| ST8Sia1 | Ganglioside D3 synthase |
| SMPDL3b | Sphingomyelinase-like phosphodiesterase 3b |
| ST3Gal1 | alpha-2,3-sialyltransferase |
| ST3Gal5 | Ganglioside M3 synthase |
| SLE | systemic lupus erythematosus |
| TCR | T-cell receptor |
| VEGF | Vascular endothelial growth factor |